FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094242096> ?p ?o ?g. }

• W3094242096 endingPage "713" @default.
• W3094242096 startingPage "699" @default.
• W3094242096 abstract "Abstract Long non-coding RNAs (lncRNAs) have been widely reported to regulate the development and chemoresistance of a variety of tumors. Temozolomide (TMZ) is a first-line chemotherapy for treatment of glioma. However, the effect and the regulatory mechanism of lncRNA MSC-AS1 (MSC-AS1) in TMZ-resistant glioma remain unrevealed. Levels of MSC-AS1, microRNA-373-3p (miR-373-3p), and cytoplasmic polyadenylation element binding protein 4 (CPEB4) were determined by quantitative real-time polymerase chain reaction (qRT-PCR). All protein expression was detected by western blot. Cell viability and the half maximal inhibitory concentration (IC 50 ) value of TMZ was assessed by cell counting kit-8 (CCK-8) assay. Cell cloning ability and apoptosis were examined by colony formation and flow cytometry assays, respectively. Dual-luciferase reporter and RNA immunoprecipitation (RIP) assays were performed to verify the correlation between miR-373-3p and MSC-AS1 or CPEB4. The xenograft models were established to determine the effect of MSC-AS1 in vivo. MSC-AS1 was up-regulated in TMZ-resistant glioma tissues and cells, and glioma patients with high MSC-AS1 expression tend to have lower overall survival rate. MSC-AS1 suppression reduced the IC 50 value of TMZ and proliferation, promoted apoptosis and TMZ sensitivity, and affected PI3K/Akt pathway in TMZ-resistant glioma cells. MSC-AS1 acted as miR-373-3p sponge, and miR-373-3p directly targeted CPEB4. Silencing miR-373-3p reversed the promoting effect of MSC-AS1 or CPEB4 knockdown on TMZ sensitivity. Furthermore, MSC-AS1 knockdown inhibited TMZ-resistant glioma growth in vivo by regulating miR-373-3p/CPEB4 axis through PI3K/Akt pathway. Collectively, MSC-AS1 knockdown suppressed cell growth and the chemoresistance of glioma cells to TMZ by regulating miR-373-3p/CPEB4 axis in vitro and in vivo through activating PI3K/Akt pathway." @default.
• W3094242096 created "2020-10-29" @default.
• W3094242096 creator A5052371333 @default.
• W3094242096 creator A5072438444 @default.
• W3094242096 creator A5081469211 @default.
• W3094242096 date "2020-10-26" @default.
• W3094242096 modified "2023-10-17" @default.
• W3094242096 title "MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway" @default.
• W3094242096 cites W1970760326 @default.
• W3094242096 cites W1976031126 @default.
• W3094242096 cites W2024613683 @default.
• W3094242096 cites W2069930584 @default.
• W3094242096 cites W2120308617 @default.
• W3094242096 cites W2158681922 @default.
• W3094242096 cites W2167713837 @default.
• W3094242096 cites W2174342911 @default.
• W3094242096 cites W2239142370 @default.
• W3094242096 cites W2320620617 @default.
• W3094242096 cites W2328671688 @default.
• W3094242096 cites W2333647903 @default.
• W3094242096 cites W2536818565 @default.
• W3094242096 cites W2553684064 @default.
• W3094242096 cites W2578248437 @default.
• W3094242096 cites W2580196525 @default.
• W3094242096 cites W2591596179 @default.
• W3094242096 cites W2594978979 @default.
• W3094242096 cites W2598665375 @default.
• W3094242096 cites W2616299974 @default.
• W3094242096 cites W2749896527 @default.
• W3094242096 cites W2783313001 @default.
• W3094242096 cites W2792849662 @default.
• W3094242096 cites W2809092704 @default.
• W3094242096 cites W2889647842 @default.
• W3094242096 cites W2909450737 @default.
• W3094242096 cites W2921493769 @default.
• W3094242096 cites W2924684777 @default.
• W3094242096 cites W2950635421 @default.
• W3094242096 cites W2962354828 @default.
• W3094242096 cites W2974101671 @default.
• W3094242096 cites W2990653076 @default.
• W3094242096 cites W2997248272 @default.
• W3094242096 cites W2999612237 @default.
• W3094242096 cites W3003449774 @default.
• W3094242096 cites W3021554718 @default.
• W3094242096 cites W3032452981 @default.
• W3094242096 cites W3033746847 @default.
• W3094242096 cites W573094082 @default.
• W3094242096 doi "https://doi.org/10.1007/s11010-020-03937-x" @default.
• W3094242096 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7873112" @default.
• W3094242096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33106913" @default.
• W3094242096 hasPublicationYear "2020" @default.
• W3094242096 type Work @default.
• W3094242096 sameAs 3094242096 @default.
• W3094242096 citedByCount "22" @default.
• W3094242096 countsByYear W30942420962021 @default.
• W3094242096 countsByYear W30942420962022 @default.
• W3094242096 countsByYear W30942420962023 @default.
• W3094242096 crossrefType "journal-article" @default.
• W3094242096 hasAuthorship W3094242096A5052371333 @default.
• W3094242096 hasAuthorship W3094242096A5072438444 @default.
• W3094242096 hasAuthorship W3094242096A5081469211 @default.
• W3094242096 hasBestOaLocation W30942420961 @default.
• W3094242096 hasConcept C153911025 @default.
• W3094242096 hasConcept C173396325 @default.
• W3094242096 hasConcept C185592680 @default.
• W3094242096 hasConcept C190283241 @default.
• W3094242096 hasConcept C2777389519 @default.
• W3094242096 hasConcept C2778227246 @default.
• W3094242096 hasConcept C502942594 @default.
• W3094242096 hasConcept C54355233 @default.
• W3094242096 hasConcept C553184892 @default.
• W3094242096 hasConcept C55493867 @default.
• W3094242096 hasConcept C62112901 @default.
• W3094242096 hasConcept C62478195 @default.
• W3094242096 hasConcept C75217442 @default.
• W3094242096 hasConcept C81885089 @default.
• W3094242096 hasConcept C86554907 @default.
• W3094242096 hasConcept C86803240 @default.
• W3094242096 hasConcept C95444343 @default.
• W3094242096 hasConceptScore W3094242096C153911025 @default.
• W3094242096 hasConceptScore W3094242096C173396325 @default.
• W3094242096 hasConceptScore W3094242096C185592680 @default.
• W3094242096 hasConceptScore W3094242096C190283241 @default.
• W3094242096 hasConceptScore W3094242096C2777389519 @default.
• W3094242096 hasConceptScore W3094242096C2778227246 @default.
• W3094242096 hasConceptScore W3094242096C502942594 @default.
• W3094242096 hasConceptScore W3094242096C54355233 @default.
• W3094242096 hasConceptScore W3094242096C553184892 @default.
• W3094242096 hasConceptScore W3094242096C55493867 @default.
• W3094242096 hasConceptScore W3094242096C62112901 @default.
• W3094242096 hasConceptScore W3094242096C62478195 @default.
• W3094242096 hasConceptScore W3094242096C75217442 @default.
• W3094242096 hasConceptScore W3094242096C81885089 @default.
• W3094242096 hasConceptScore W3094242096C86554907 @default.
• W3094242096 hasConceptScore W3094242096C86803240 @default.
• W3094242096 hasConceptScore W3094242096C95444343 @default.
• W3094242096 hasIssue "2" @default.
• W3094242096 hasLocation W30942420961 @default.

• next